Get startedLog in
    Picture of Agilent Technologies logo

    A — Agilent Technologies Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Agilent Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

    2021
    October 31st
    2022
    October 31st
    2023
    October 31st
    2024
    October 31st
    2025
    October 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1,2101,2541,2401,2891,303
    Depreciation
    Deferred Taxes
    Non-Cash Items42211433186229
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-102-478-11683-131
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities1,4851,3121,7721,7511,559
    Capital Expenditures-189-291-298-378-407
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-560-47-12-88013
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-749-338-310-1,258-394
    Financing Cash Flow Items-83-67-122-39-29
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-696-1,372-930-752-715
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash43-434537-261459